GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nanosonics NAN.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

2.89

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$203.5m

FY2017FY2026

Net income

A$17.8m

FY2017FY2026

Free cash flow

A$17.4m

FY2017FY2026

Shareholders' equity

A$217.5m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$203.5mA$198.9mA$171.6mA$167.5mA$119.7mA$101.8mA$99.4mA$84.3mA$60.7mA$67.5m
Gross profitA$148.6mA$155.7mA$134.0mA$125.7mA$86.2mA$74.9mA$71.1mA$62.8mA$45.3mA$50.2m
Research and developmentA$29.1mA$34.7mA$32.8mA$27.3mA$21.5mA$16.2mA$14.6mA$11.4mA$9.9mA$9.5m
Operating incomeA$15.0mA$8.9mA$9.1mA$18.0mA$792,000A$8.4mA$12.0mA$13.7mA$2.8mA$13.1m
Net incomeA$17.8mA$20.7mA$13.0mA$19.9mA$3.7mA$8.6mA$10.1mA$13.6mA$5.8mA$26.2m
Diluted earnings per share0.060.070.040.070.010.030.030.040.020.09

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$310.5mA$272.5mA$237.3mA$226.1mA$193.2mA$164.6mA$148.2mA$129.5mA$109.2mA$99.3m
Cash and short-term investmentsA$155.2mA$161.3mA$129.6mA$112.2mA$94.5mA$96.0mA$91.8mA$72.2mA$69.4mA$63.0m
Total liabilitiesA$93.0mA$62.6mA$55.1mA$62.2mA$54.5mA$29.0mA$24.0mA$19.4mA$14.9mA$12.0m
DebtA$23.1mA$7.7mA$9.3mA$10.7mA$11.7mA$2.5mA$2.6mA$521,000A$946,000A$1.4m
Shareholders' equityA$217.5mA$209.9mA$182.2mA$163.9mA$138.7mA$135.6mA$124.2mA$110.1mA$94.3mA$87.3m
Shares outstanding309m309m309m306m305m305m305m304m302m301m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$22.6mA$44.0mA$22.8mA$23.3mA$6.7mA$7.3mA$22.8mA$4.8mA$9.0mA$16.4m
Capital spending−A$5.1m−A$8.7m−A$2.5m−A$3.6m−A$7.0m−A$1.4m−A$1.9m−A$1.7m−A$2.3m−A$1.1m
Free cash flowA$17.4mA$35.3mA$20.3mA$19.7m−A$271,000A$5.9mA$20.8mA$3.1mA$6.7mA$15.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
RevenueA$101.0mA$102.5mA$104.9mA$93.6mA$90.4mA$80.7mA$85.7mA$42.2m
Gross profitA$78.1mA$78.2mA$81.8mA$73.4mA$69.0mA$64.5mA$67.6mA$33.1m
Operating incomeA$6.3mA$8.7mA$9.9mA$8.7mA$6.1mA$3.6mA$7.9mA$3.7m
Net incomeA$8.2mA$9.6mA$10.9mA$9.8mA$6.8mA$6.2mA$9.5mA$4.8m
Diluted earnings per share0.030.030.040.030.020.020.030.02
Cash from operationsA$15.0mA$6.0mA$22.0mA$21.0mA$13.0mA$9.0mA$15.0mA$7.0m
Capital spending−A$2.0m−A$2.0m−A$2.0m−A$5.0m−A$1.0m−A$1.0m−A$1.0m—
Free cash flowA$13.0mA$4.0mA$20.0mA$16.0mA$12.0mA$8.0mA$14.0m—
Total assetsA$310.5mA$279.3mA$272.5mA$255.0mA$237.3mA$227.1mA$226.1mA$219.9m
Cash and short-term investmentsA$155.2mA$159.8mA$161.3mA$144.5mA$129.6mA$118.3mA$112.2mA$112.2m
DebtA$3.0mA$6.7mA$7.7mA$9.2mA$9.3mA$10.7mA$10.7m—
Shareholders' equityA$217.5mA$219.7mA$209.9mA$189.0mA$182.2mA$175.5mA$163.9mA$139.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.7%14.8%16.9%
Operating income-5.9%12.3%—
Net income-3.6%15.8%64.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin75.6%76.1%75.3%74.9%
Operating margin5.9%6.9%6.3%7.7%
Net margin9.6%9.6%8.7%10.6%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings51.159.671.467.5349.9227.0241.3141.8149.431.9
Price to sales4.56.25.48.010.919.124.622.914.212.4

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.